Literature DB >> 26578260

Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome?

Rachel Harwood1, David Wilkinson2, Shweta Ramkumar3, Gillian Humphrey4.   

Abstract

PURPOSE: Haemolytic uraemic syndrome (HUS) is the commonest childhood cause of acute renal failure. Peritoneal dialysis peritonitis (PDP) is a well-recognised complication, with some children requiring surgical intervention (SI). The aim of this study is to determine whether the presence of enteric organisms in cases of PDP might predict the need for SI.
METHODS: Retrospective, 5-year (2009-2014) case note review of all HUS cases requiring PD presenting to a single centre. Mann-Whitney U test was used for continuous non-parametric data and χ (2) for categorical data.
RESULTS: 48 children required PD for HUS, 18/48 (38 %) developed PDP and of these 5/18 (28 %) required SI (subtotal colectomy n = 4, small bowel resection n = 1). Peritoneal fluid was cultured as part of the work-up for PDP. The presence of enteric organisms was associated with a 10.4 fold relative risk of requiring surgery (p = 0.02, 95 % CI 1.5-71.9), with 4/5 of these patients requiring surgery (median 17 days post-culture result). Only 1/13 patients not requiring surgery grew gram-negative bacteria.
CONCLUSION: The presence of enteric bacteria in patients with PDP significantly decreases the chances of successful conservative management. In these patients early involvement of the surgical team is essential with a low threshold for SI.

Entities:  

Keywords:  Enteric bacteria; Gram-negative organisms; Haemolytic Uraemic Syndrome; Paediatric; Peritoneal dialysis; Peritonitis; Surgery

Mesh:

Year:  2015        PMID: 26578260     DOI: 10.1007/s00383-015-3833-6

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  22 in total

1.  Impact of infection by verotoxigenic Escherichia coli O157:H7 on the use of surgical services in a children's hospital.

Authors:  N Cimolai; G K Blair; J J Murphy; G G Fraser
Journal:  Can J Surg       Date:  1997-02       Impact factor: 2.089

Review 2.  Escherichia coli O157:H7 and the hemolytic-uremic syndrome.

Authors:  T G Boyce; D L Swerdlow; P M Griffin
Journal:  N Engl J Med       Date:  1995-08-10       Impact factor: 91.245

3.  The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.

Authors:  D L Martin; K L MacDonald; K E White; J T Soler; M T Osterholm
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

4.  Indications for laparotomy in infection with verotoxigenic Escherichia coli.

Authors:  K Vanamo
Journal:  Pediatr Surg Int       Date:  2000       Impact factor: 1.827

5.  [Hemolytic-uremic syndrome. Experience with 154 cases].

Authors:  J Cordero; J Baeza; O Fielbaum; C Saieh; M Varela; E Rodríguez; P Olivos; C Hernández; J González
Journal:  Rev Chil Pediatr       Date:  1990 Sep-Oct

Review 6.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

Review 7.  Hemolytic uremic syndrome: an emerging health risk.

Authors:  Samiya Razzaq
Journal:  Am Fam Physician       Date:  2006-09-15       Impact factor: 3.292

8.  An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.

Authors:  Sebastian Loos; Thurid Ahlenstiel; Brigitta Kranz; Hagen Staude; Lars Pape; Christoph Härtel; Udo Vester; Laura Buchtala; Kerstin Benz; Bernd Hoppe; Ortraud Beringer; Martin Krause; Dominik Müller; Martin Pohl; Johanna Lemke; Georg Hillebrand; Martin Kreuzer; Jens König; Marianne Wigger; Martin Konrad; Dieter Haffner; Jun Oh; Markus J Kemper
Journal:  Clin Infect Dis       Date:  2012-06-05       Impact factor: 9.079

Review 9.  Escherichia coli O157:H7.

Authors:  P S Mead; P M Griffin
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

10.  The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.

Authors:  L Byrne; C Jenkins; N Launders; R Elson; G K Adak
Journal:  Epidemiol Infect       Date:  2015-04-29       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.